HnRNP-L-regulated circCSPP1/miR-520h/EGR1 axis modulates autophagy and promotes progression in prostate cancer
2021 · Molecular Therapy — Nucleic Acids · 51 citations
https://doi.org/10.1016/j.omtn.2021.10.006
C
Chuanfan Zhong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
578
Citations
8
h-index
8
i10-index
Chuanfan Zhong is an academic researcher from Zhujiang Hospital. The author has contributed to research in topics: Cancer-related molecular mechanisms research & RNA modifications and cancer & Circular RNAs in diseases. The author has an h-index of 8, co-authored 24 publications.
ORCID: 0000-0002-0824-1517Papers by this author
worksA prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer
2023 · Translational Oncology · 8 citations
https://doi.org/10.1016/j.tranon.2023.101670
GG-NER’s role in androgen receptor signaling inhibitor response for advanced prostate cancer
2024 · Cell Communication and Signaling · 4 citations
https://doi.org/10.1186/s12964-024-01977-0
Additional file 7 of Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.20088203
Additional file 6 of Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.20088200
Exosome-transmitted long noncoding RNA SNHG1 promotes prostate cancer bone metastasis via YBX1/MMP16 axis
2026 · Cell Death Discovery · 0 citations
https://doi.org/10.1038/s41420-025-02855-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat